A recent paper by Fanning et al. in Nature Reviews Drug Discovery provides a very useful critical review of the recent literature that describes the rationale for curative therapies and the resulting compounds that are being tested in clinical trials for hepatitis B. To access this paper click here.

In July, 2019 the WHO published their progress report on three aligned global health sector strategies on HIV, viral hepatitis and sexually transmitted infections. These strategies were endorsed in 2016 at the 69th World Health Assembly by WHO Member States to guide actions over the period of 2016-2021 towards eliminating these diseases by 2030.

The WHO maintains a comprehensive list of compelling facts highlighting the global burden of hepatitis B.